Skip to main content

Your search for “antibody” returned 203 results

UC San Diego Sparks New Cancer-Focused Startup, Oncternal, with Exclusive Antibody License

May 2, 2016

Oncternal Therapeutics, a new cancer-focused biotechnology startup, has signed a wide-ranging licensing agreement with UC San Diego to develop and commercialize antibodies and antibody-related binding agents.

Artificial Intelligence Aids Discovery of Super Tight-Binding Antibodies

January 31, 2023

UC San Diego scientists developed an artificial intelligence tool that could accelerate the development of new high affinity antibody drugs.

How Protective are COVID Antibodies?

January 27, 2022

…How Protective are COVID Antibodies? Campus volunteers needed for largest study to date to understand Covid-19 immunity. The University of California San Diego is conducting what is believed to be the largest research study yet of SARS-CoV-2 antibodies and the protection they impart against contracting COVID-19. The ZAP COVID-19 (NeutraliZing…

UC San Diego Researchers Continue to Make Strides in Research Reproducibility

October 19, 2016

Experts at the recent Global Biological Standards Institute workshop — as well as Cell Press and Thermo Fisher Scientific — have agreed to adopt reproducibility standards first proposed by QI affiliate Anita Bandrowski and her colleagues.

Research Demonstrates Implications of Cost for COVID-19 Antibody Testing

November 5, 2020

…of Cost for COVID-19 Antibody Testing Testing for COVID-19 antibodies can provide important information for communities battling an outbreak. These tests can inform epidemiologists whether someone has had an infection, even if they were asymptomatic. Yet for testing to provide a good understanding, take-up needs to be broad and independent…

Monoclonal Antibody Targets, Kills Leukemia Cells

March 25, 2013

Researchers at the University of California, San Diego Moores Cancer Center have identified a humanized monoclonal antibody that targets and directly kills chronic lymphocytic leukemia (CLL) cells.

Genetics May Play Role in Determining Immunity to COVID-19

February 18, 2021

UC San Diego researchers report that individual immune response to SARS-CoV-2 may be limited by a set of variable genes that code for cell surface proteins essential for the adaptive immune system. The finding may help explain why COVID-19 immunity varies by individual.

UC San Diego Health Launches Novel Coronavirus Blood Testing to Identify Past Exposure

April 17, 2020

Physicians and scientists at UC San Diego Health have launched a pair of serological tests that will look for novel coronavirus antibodies—evidence in persons tested that they have previously been infected by the viral cause of COVID-19, even if they never experienced tell-tale symptoms.

Imitation May Be a Sincere Form of Treatment

August 5, 2020

The National Institutes of Health will soon launch a Phase II clinical trial to evaluate the safety and efficacy of potential new therapeutics for COVID-19, including the use of investigational synthetic monoclonal antibodies. Davey Smith of UC San Diego is the protocol chair and answers questions.

For Good and Ill, Immune Response to Cancer Cuts Both Ways

April 7, 2014

The difference between an immune response that kills cancer cells and one that conversely stimulates tumor growth can be as narrow as a “double-edged sword,” report researchers at the University of California, San Diego School of Medicine in the April 7, 2014 online issue of the Proceedings of the National…

Category navigation with Social links